Abstract:Luis H. Toledo-Pereyra Editor-in-Chief R esearch in general, and surgical research in particular, requires continuous sources of internal or external support. Since internal support has become scarce and dif cult to secure, researchers need to develop new strategies for maximizing external support. Such support comes from several major sources: federal and state agencies, national and local foundations, and industry. To increase their chances for success, individual researchers should de ne their particular strengths when seeking funding. Federal funding comes primarily from the National Institutes of Health (NIH), the premier American research institution. NIH offers the largest and most consistent grants for medical and surgical research. However, the young and inexperienced researcher has the least opportunity to succeed at NIH, where reputation and prestige are important. Young researchers seeking NIH support should nd a good mentor who is knowledgeable about grant writing and understands the federal system. NIH reviewers consider ve strategic areas when assessing grant applications: signi cance, approach, innovation, investigator’s background, and institutional environment. These ve criteria do not receive equal weight [1]. Therefore, applicants should draw on the mentor’s experience and guidance in deciding which criteria should be emphasized and how competency can be demonstrated. One thing is certain the process takes time, dedication, and persistence! Several other federal sources of funding deserve special mention, including the National Science Foundation and the Department of Defense. State funding has usually been small compared with federal spending, but money from the tobacco settlement has been allocated to health research in some states. In Michigan, for example, the state developed the Michigan Life Sciences Corridor, which solicits competitive grant applications from Michigan scientists. Other sources of state funding are usually for research in the clinical or social sciences. Preference is often given to projects addressing unmet health needs or underserved populations. Surgical investigators should not shy away from applying for state funds. Research grant of ces, whose personnel can direct investigators to appropriate resources, are the best source of information about local and national foundations. Nonpro t foundations include for example:

Structural Basis of CD160:HVEM Recognition.

Clinical Significance of Herpes Virus Entry Mediator Expression in Hepatitis B Virus-Related Hepatocellular Carcinoma.

Surgical Research Funding

Structures of HCMV Trimer reveal the basis for receptor recognition and cell entry

Structural basis for CD97 recognition of the decay-accelerating factor CD55 suggests mechanosensitive activation of adhesion GPCRs

Structure–function Correlations in Vertebrate Defensins

Multilayered Computational Framework for Designing Peptide Inhibitors of HVEM-LIGHT Interaction

Mild illness at or after measles vaccination does not reduce seroresponse in young children.

Crystal structure of the HSV-1 Fc receptor bound to Fc reveals a mechanism for antibody bipolar bridging.

Structural basis of the dynamic human CEACAM1 monomer-dimer equilibrium

Sexual dimorphism and development of the human cochlea. Computer 3-D measurement.

Structural aspects of CEACAM1 interactions

Critical residues and motifs for homodimerization of the first transmembrane domain of the plasma membrane glycoprotein CD36

CD94-NKG2A recognition of human leukocyte antigen (HLA)-E bound to an HLA class I leader sequence

Structural insight into CD93 recognition by IGFBP7

The incredible bulk: Human cytomegalovirus tegument architectures uncovered by AI-empowered cryo-EM

The Role of Herpesvirus Entry Mediator As a Negative Regulator of T Cell–mediated Responses

Human leukocyte antigen E in human cytomegalovirus infection: friend or foe?

EXPERT SYSTEM USING HYBRIDISM AMONG SYMBOLIC AND CONNECTIONIST PARADIGMS , FUZZY LOGIC AND , GENETIC ALGORITHMS

Molecular Architecture of the Erbb2 Extracellular Domain Homodimer

Human CD16 as a lysis receptor mediating direct natural killer cell cytotoxicity